Terms: = Skin cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB
1769 results:
1. GZ17-6.02 kills PDX isolates of uveal melanoma.
Booth L; Roberts JL; Spasojevic I; Baker KC; Poklepovic A; West C; Kirkwood JM; Dent P
Oncotarget; 2024 May; 15():328-344. PubMed ID: 38758815
[TBL] [Abstract] [Full Text] [Related]
2. Erythema dyschromicum perstans-like eruptions induced by epidermal growth factor receptor inhibitors in patients with lung cancer.
Bang AS; Said JT; Hirner J; Rana J; Pugliese S; Wang JY; Zaba L; Zhao L; Doan L; Smith J; Kwong BY
Support Care Cancer; 2024 May; 32(6):354. PubMed ID: 38750379
[TBL] [Abstract] [Full Text] [Related]
3. CD133 Stimulates Cell Proliferation via the Upregulation of Amphiregulin in Melanoma.
Simbulan-Rosenthal CM; Islam N; Haribabu Y; Alobaidi R; Shalamzari A; Graham G; Kuo LW; Sykora P; Rosenthal DS
Cells; 2024 May; 13(9):. PubMed ID: 38727313
[TBL] [Abstract] [Full Text] [Related]
4.
Zhao A; Wang Y; Wang Z; Shao Q; Gong QI; Zhu H; Shen S; Liu HU; Chen X
Oncol Res; 2024; 32(5):983-998. PubMed ID: 38686044
[TBL] [Abstract] [Full Text] [Related]
5. Decoding dynamic interactions between egfr-TKD and DAC through computational and experimental approaches: A novel breakthrough in lung melanoma treatment.
Meher RK; Mir SA; Singh K; Mukerjee N; Nayak B; Kumer A; Zughaibi TA; Khan MS; Tabrez S
J Cell Mol Med; 2024 May; 28(9):e18263. PubMed ID: 38685671
[TBL] [Abstract] [Full Text] [Related]
6. miRSNP rs188493331: A key player in genetic control of microRNA-induced pathway activation in hypertrophic scars and keloids.
Chen M; Pan Y; Chen Z; Qi F; Gu J; Qiu Y; He A; Liu J
Skin Res Technol; 2024 May; 30(5):e13686. PubMed ID: 38682767
[TBL] [Abstract] [Full Text] [Related]
7. Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild-type metastatic colorectal cancer: A phase II trial (HYBRID).
Arai H; Tsuda T; Sunakawa Y; Shimokawa M; Akiyoshi K; Tokunaga S; Shoji H; Kunieda K; Kotaka M; Matsumoto T; Nagata Y; Mizukami T; Mizuki F; Danenberg KD; Boku N; Nakajima TE
Cancer Med; 2024 Apr; 13(7):e7107. PubMed ID: 38591098
[TBL] [Abstract] [Full Text] [Related]
8. Endocytic activation and exosomal secretion of matriptase stimulate the second wave of EGF signaling to promote skin and breast cancer invasion.
Ye F; Yuan Z; Tang Y; Li J; Liu X; Sun X; Chen S; Ye X; Zeng Z; Zhang XK; Zhou H
Cell Rep; 2024 Apr; 43(4):114002. PubMed ID: 38547126
[TBL] [Abstract] [Full Text] [Related]
9. Role of Surgery in Metastatic Melanoma and Review of Melanoma Molecular Characteristics.
Sukniam K; Manaise HK; Popp K; Popp R; Gabriel E
Cells; 2024 Mar; 13(6):. PubMed ID: 38534309
[TBL] [Abstract] [Full Text] [Related]
10. Association between skin toxicity and efficacy of necitumumab in squamous non-small-cell lung cancer: a pooled analysis of two randomized clinical trials-SQUIRE and JFCM.
Watanabe S; Yoshioka H; Sakai H; Hotta K; Takenoyama M; Yamada K; Sugawara S; Takiguchi Y; Hosomi Y; Tomii K; Niho S; Nishio M; Kato T; Takahashi T; Ebi H; Aono M; Yamamoto N; Ohe Y; Nakagawa K
ESMO Open; 2024 Apr; 9(4):102975. PubMed ID: 38520847
[TBL] [Abstract] [Full Text] [Related]
11. Mobocertinib: Mechanism of action, clinical, and translational science.
Hanley MJ; Camidge DR; Fram RJ; Gupta N
Clin Transl Sci; 2024 Mar; 17(3):e13766. PubMed ID: 38511563
[TBL] [Abstract] [Full Text] [Related]
12. Antibody dependent cellular cytotoxicity-inducing anti-egfr antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors.
Muraro E; Montico B; Lum B; Colizzi F; Giurato G; Salvati A; Guerrieri R; Rizzo A; Comaro E; Canzonieri V; Anichini A; Del Vecchio M; Mortarini R; Milione M; Weisz A; Pizzichetta MA; Simpson F; Dolcetti R; Fratta E; Sigalotti L
Front Immunol; 2024; 15():1336566. PubMed ID: 38510242
[TBL] [Abstract] [Full Text] [Related]
13. Diseases categorized as autoinflammatory keratinization diseases (AiKDs), and their pathologies and treatments.
Akiyama M
Nagoya J Med Sci; 2024 Feb; 86(1):1-15. PubMed ID: 38505726
[TBL] [Abstract] [Full Text] [Related]
14. Nanobody-mediated targeting of zinc phthalocyanine with polymer micelles as nanocarriers.
Mesquita B; Singh A; Prats Masdeu C; Lokhorst N; Hebels ER; van Steenbergen M; Mastrobattista E; Heger M; van Nostrum CF; Oliveira S
Int J Pharm; 2024 Apr; 655():124004. PubMed ID: 38492899
[TBL] [Abstract] [Full Text] [Related]
15. Thyroid dysfunction after immune checkpoint inhibitors in a single-centre UK pan-cancer cohort: A retrospective study.
Kennedy OJ; Ali N; Lee R; Monaghan P; Adam S; Cooksley T; Lorigan P
Eur J Cancer; 2024 May; 202():113949. PubMed ID: 38432099
[TBL] [Abstract] [Full Text] [Related]
16. Sunset Yellow protects against oxidative damage and exhibits chemoprevention in chemically induced skin cancer model.
Singh S; Yadav S; Cavallo C; Mourya D; Singh I; Kumar V; Shukla S; Shukla P; Chaudhary R; Maurya GP; Müller RLJ; Rohde L; Mishra A; Wolkenhauer O; Gupta S; Tripathi A
NPJ Syst Biol Appl; 2024 Mar; 10(1):23. PubMed ID: 38431714
[TBL] [Abstract] [Full Text] [Related]
17. Gemcitabine and nab-paclitaxel combined with afatinib in metastatic pancreatic cancer - Results of a phase 1b clinical trial.
Zhang D; Benedikt Westphalen C; Quante M; Waldschmidt DT; Held S; Kütting F; Dorman K; Heinrich K; Weiss L; Boukovala M; Haas M; Boeck S; Heinemann V; Probst V
Eur J Cancer; 2024 Apr; 201():113926. PubMed ID: 38401449
[TBL] [Abstract] [Full Text] [Related]
18. Mechanism of action of adapalene for treating egfr-TKI-induced skin disorder.
Mimura C; Nagano T; Miwa N; Matsumura K; Yamada J; Satoh H; Suraya R; Hazama D; Tamura D; Yamamoto M; Tachihara M; Nishimura Y; Kobayashi K
Thorac Cancer; 2024 Mar; 15(9):722-729. PubMed ID: 38379420
[TBL] [Abstract] [Full Text] [Related]
19. Effects of rosmarinic acid and doxorubicine on an ovarian adenocarsinoma cell line (OVCAR3) via the egfr pathway.
Sarı U; Zaman F
Acta Cir Bras; 2024; 39():e390524. PubMed ID: 38324801
[TBL] [Abstract] [Full Text] [Related]
20. Potential Efficacy of Shiunko for Anti-Epidermal Growth Factor Receptor (egfr) Monoclonal Antibody-Induced skin Fissure: A Single Institutional Case Series.
Okunaka M; Kotani D; Mishima S; Nakamura M; Kawazoe A; Bando H; Yoshino T; Shitara K
Integr Cancer Ther; 2024; 23():15347354231225962. PubMed ID: 38240253
[TBL] [Abstract] [Full Text] [Related]
[Next]